Summary

The breathing circuits market is expected to grow to USD 2.16 billion by 2029 from an estimated USD 1.57 billion in 2024, at a CAGR of 6.5% during the forecast period. Improvements in breathing circuit technology is one of the major drivers of the market. Within the past couple of years, new initiatives and efforts taken towards enhancing safety, comfort, and efficiency-oriented development have resulted in increasingly sophisticated and efficient forms of breathing circuits. For instance, breathing circuits that feature inbuilt humidification, antimicrobial filters, and advanced ergonomic designs have added to a much greater effect in delivering respiratory support while reducing infections and discomfort. Moreover, with advanced materials used in production, breathing circuits become more biocompatible and resistant. Such technological advancements by different key players will lead to increased adoption of breathing circuits, thus driving the market growth in the coming years.
“Adult patients segment accounted for the highest growth rate in the breathing circuits market, by patient type, during the forecast period.”
Based on patient type, the breathing circuits market is bifurcated into adult patients and pediatric and neonatal patients. The adult patients segment expected to have the highest CAGR during the forecast period. The growth in this patient segment is driven by the increasing rate of adult surgical interventions, especially complex and high-risk cases needing breathing circuits for anesthesia and respiratory support. Furthermore, the aging population and rising prevalence of chronic respiratory disorders, such as COPD, asthma, and sleep apnea, are often associated with the use of advanced breathing circuits, especially in surgical procedures, which further support this segment's growth. Moreover, sedentary life, poor diet, and smoking act also as major contributory factors to such conditions and hence increase the demand for advanced breathing circuits in managing and treating respiratory diseases in adults.
“Dual-limb Breathing Circuits segment is expected to have the fastest growth rate in the breathing circuits market, by circuit type, during the forecast period.”
The breathing circuits market is segmented into single-limb breathing circuits and dual-limb breathing circuits, based on circuit type. Dual-limb breathing circuits are projected to account for the highest CAGR during the forecast period. Dual-limb breathing circuits are likely to witness a huge demand, as they offer numerous advantages for critical and specialized medical applications. One major factor is that they provide two distinct and controlled channels for inhalation and exhalation, which increases the efficiency of ventilation by preventing rebreathing of exhaled carbon dioxide. This would be very important in ICUs and OTs, where it would be important to correct management of gases in order to ensure patient safety and optimum respiratory support. Another advantage of dual-limb circuits is that accessories, like humidifiers, filters, and monitoring equipment, can be fitted to facilitate appropriate and comprehensive care for the patient. Added to this is the fact that these circuits can adapt to different patients and different medical interventions that further increase their applicability in healthcare.
“Asia Pacific: The fastest-growing region in breathing circuits market.”
The worldwide market for breathing circuits is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. The Asia Pacific region, a hub for medical tourism, is rapidly emerging as a leader in the market for medical procedures and devices. Growth in this market is driven by several factors, that include the increased investment and modernization in the health care infrastructure, which improves the availability as well as the quality of medical services. Rising patient population and occurrences of chronic respiratory diseases further fuel the demand. Moreover, high economic growth in developing countries, including China, India, and others, has led to increases in health care expenditures and the demand for more modern medical devices, including breathing circuits.
The break-up of the profile of primary participants in the breathing circuits market:
• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in this market are Drägerwerk AG & Co. KGaA (Germany), Medtronic (Ireland), Cardinal Health (US), Fisher & Paykel Healthcare Limited (New Zealand), ResMed (US), Ambu A/S (Denmark), GE Healthcare (US), ICU Medical, Inc. (US), Koninklijke Philips N.V. (Netherlands), Hamilton Medical (Switzerland), Medline Industries, LP (US), Forca Healthcare (India), Braun & Co. Limited (UK), Inspiration Healthcare Group PLC (UK), Besmed Health Business Corp. (Taiwan), Eakin Healthcare (UK), BOMIMED (Canada), Flexicare (Group) Limited (UK), Bio-Med Devices (US), Airlife (US), Mercury Medical (US), Intersurgical Ltd (UK), Fairmont Medical Products Pty Ltd. (Australia), Breas Medical AB (Sweden), and GPC Medical Ltd. (India).
Research Coverage:
This research report categorizes the breathing circuits market by usage (disposable breathing circuits and reusable breathing circuits), by patient type (adult patients and pediatric and neonatal patients), by circuit type (single-limb breathing circuits and dual-limb breathing circuits), by application (anesthesia, respiratory dysfunction, and other applications), by end user (hospitals, ambulatory surgical centers, clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the breathing circuits market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the breathing circuits market. Competitive analysis of upcoming startups in the breathing circuits market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall breathing circuits market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (growing prevalence of respiratory diseases, rising number of emergency cases globally, increasing number of surgical procedures, and technological advancements), opportunities (Growth opportunities in emerging economies), restraints (Unfavorable reimbursement scenario and high risk of infection associated with reusable breathing circuits), and challenges (environmental concerns related to single-use and non-biodegradable breathing circuits) influencing the growth of the breathing circuits market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the breathing circuits market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the breathing circuits market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breathing circuits market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Drägerwerk AG & Co. KGaA (Germany), Medtronic (Ireland), Cardinal Health (US), Fisher & Paykel Healthcare Limited (New Zealand), and ResMed (US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 SEGMENTS CONSIDERED 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key secondary sources 31
2.1.1.2 Key data from secondary sources 32
2.1.1.3 Objectives of secondary research 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Key primary sources 33
2.1.2.2 Key data from primary sources 34
2.1.2.3 Key industry insights 35
2.1.2.4 Breakdown of primaries 35
2.2 MARKET SIZE ESTIMATION 36
2.2.1 BOTTOM-UP APPROACH 37
2.2.1.1 Company revenue estimation approach 37
2.2.1.2 Company presentations and primary interviews 37
2.2.1.3 Growth forecast 38
2.2.1.4 CAGR projections 38
2.2.2 TOP-DOWN APPROACH 38
2.3 DATA TRIANGULATION 40
2.4 MARKET SHARE ANALYSIS 41
2.5 STUDY ASSUMPTIONS 41
2.6 GROWTH RATE ASSUMPTIONS 41
2.7 RESEARCH LIMITATIONS 42
2.8 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43

4 PREMIUM INSIGHTS 48
4.1 BREATHING CIRCUITS MARKET OVERVIEW 48
4.2 BREATHING CIRCUITS MARKET, BY USAGE, 2024 VS. 2029 48
4.3 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2024 VS. 2029 49
4.4 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2024 VS. 2029 49
4.5 BREATHING CIRCUITS MARKET, BY APPLICATION, 2024 VS. 2029 50
4.6 BREATHING CIRCUITS MARKET, BY END USER, 2024 VS. 2029 50
4.7 BREATHING CIRCUITS MARKET: REGIONAL GROWTH OPPORTUNITIES 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Growing prevalence of respiratory diseases 53
5.2.1.2 Rising number of emergency cases globally 54
5.2.1.3 Increasing number of surgical procedures 55
5.2.1.4 Technological advancements 56
5.2.2 RESTRAINTS 57
5.2.2.1 Unfavorable reimbursement scenario 57
5.2.2.2 High risk of infection associated with reusable breathing circuits 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Growth opportunities in emerging economies 58
5.2.4 CHALLENGES 58
5.2.4.1 Environmental concerns related to single-use and non-biodegradable breathing circuits 58
5.3 PRICING ANALYSIS 59
5.4 PATENT ANALYSIS 62
5.4.1 LIST OF MAJOR PATENTS 63
5.5 VALUE CHAIN ANALYSIS 64
5.6 SUPPLY CHAIN ANALYSIS 65
5.7 TRADE ANALYSIS 66
5.7.1 IMPORT DATA (HS CODE 901920) 66
5.7.2 EXPORT DATA (HS CODE 901920) 67
5.8 ECOSYSTEM ANALYSIS 67
5.8.1 ROLE IN ECOSYSTEM 68
5.9 PORTER’S FIVE FORCES ANALYSIS 69
5.9.1 THREAT OF NEW ENTRANTS 70
5.9.2 THREAT OF SUBSTITUTES 70
5.9.3 BARGAINING POWER OF BUYERS 70
5.9.4 BARGAINING POWER OF SUPPLIERS 71
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 71

5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 71
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 71
5.10.2 KEY BUYING CRITERIA 72
5.11 REGULATORY ANALYSIS 73
5.11.1 REGULATORY LANDSCAPE 73
5.11.1.1 North America 73
5.11.1.1.1 US 73
5.11.1.1.2 Canada 74
5.11.1.2 Europe 74
5.11.1.3 Asia Pacific 74
5.11.1.3.1 China 74
5.11.1.3.2 Japan 75
5.11.1.3.3 India 76
5.11.1.4 Latin America 76
5.11.1.4.1 Brazil 76
5.11.1.4.2 Mexico 76
5.11.1.5 Middle East 77
5.11.1.6 Africa 77
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
5.12 TECHNOLOGY ANALYSIS 79
5.12.1 KEY TECHNOLOGIES 79
5.12.1.1 Single-limb breathing circuits 79
5.12.2 COMPLEMENTARY TECHNOLOGIES 80
5.12.2.1 Dual-limb breathing circuits 80
5.12.3 ADJACENT TECHNOLOGIES 80
5.12.3.1 Low dead space circuits 80
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025 81
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82
5.15 INVESTMENT AND FUNDING SCENARIO 82
5.16 IMPACT OF AI/GEN AI ON BREATHING CIRCUITS MARKET 84
5.16.1 KEY USE CASES 85
6 BREATHING CIRCUITS MARKET, BY USAGE 86
6.1 INTRODUCTION 87
6.2 DISPOSABLE BREATHING CIRCUITS 87
6.2.1 GROWING EMPHASIS ON INFECTION CONTROL AND PATIENT SAFETY TO DRIVE MARKET 87
6.3 REUSABLE BREATHING CIRCUITS 91
6.3.1 COST-EFFECTIVENESS AND REDUCED ENVIRONMENTAL FOOTPRINT TO PROPEL MARKET GROWTH 91

7 BREATHING CIRCUITS MARKET, BY PATIENT TYPE 95
7.1 INTRODUCTION 96
7.2 ADULT PATIENTS 96
7.2.1 INCREASING SURGICAL PROCEDURES AND GROWING PREVALENCE OF LIFESTYLE-RELATED DISEASES TO BOOST MARKET GROWTH 96
7.3 PEDIATRIC AND NEONATAL PATIENTS 101
7.3.1 INCREASING TIMELY INTERVENTION AND TREATMENT IN PEDIATRIC CARE TO FUEL MARKET GROWTH 101
8 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 105
8.1 INTRODUCTION 106
8.2 SINGLE-LIMB BREATHING CIRCUITS 106
8.2.1 SIMPLE DESIGN AND EASE OF USE TO AID MARKET GROWTH 106
8.3 DUAL-LIMB BREATHING CIRCUITS 110
8.3.1 HIGH DEMAND FOR ADVANCED VENTILATION SOLUTIONS AND INCREASED PATIENT COMFORT TO SPUR MARKET GROWTH 110
9 BREATHING CIRCUITS MARKET, BY APPLICATION 114
9.1 INTRODUCTION 115
9.2 ANESTHESIA 115
9.2.1 INCREASING NUMBER OF SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET GROWTH 115
9.3 RESPIRATORY DYSFUNCTION 120
9.3.1 RISING PREVALENCE OF CHRONIC PULMONARY DISEASES AND SLEEP APNEA TO FUEL MARKET GROWTH 120
9.4 OTHER APPLICATIONS 124
10 BREATHING CIRCUITS MARKET, BY END USER 128
10.1 INTRODUCTION 129
10.2 HOSPITALS 129
10.2.1 INCREASING NUMBER OF HOSPITALS AND RISING GOVERNMENT HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH 129
10.3 AMBULATORY SURGERY CENTERS 133
10.3.1 FOCUS ON COST-EFFECTIVE AND IMPROVED PATIENT EXPERIENCE TO DRIVE MARKET 133
10.4 CLINICS 136
10.4.1 RISING PREVALENCE OF TARGET DISEASES TO SUPPORT MARKET GROWTH 136
10.5 OTHER END USERS 139

11 BREATHING CIRCUITS MARKET, BY REGION 143
11.1 INTRODUCTION 144
11.2 NORTH AMERICA 144
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148
11.2.2 US 148
11.2.2.1 US to dominate North American breathing circuits market during study period 148
11.2.3 CANADA 151
11.2.3.1 High geriatric population and improved healthcare infrastructure to propel market growth 151
11.3 EUROPE 154
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157
11.3.2 GERMANY 158
11.3.2.1 High healthcare spending and favorable government policies to favor market growth 158
11.3.3 FRANCE 160
11.3.3.1 Advanced healthcare system and increased number of surgeries to augment market growth 160
11.3.4 UK 163
11.3.4.1 Rising geriatric population and increasing initiatives by public and private organizations to aid market growth 163
11.3.5 ITALY 165
11.3.5.1 Improved quality of medical care and high geriatric population to spur market growth 165
11.3.6 SPAIN 168
11.3.6.1 Increased incidence of chronic diseases and improved healthcare infrastructure to drive demand 168
11.3.7 REST OF EUROPE 170
11.4 ASIA PACIFIC 173
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 177
11.4.2 JAPAN 177
11.4.2.1 Presence of universal healthcare reimbursement policy and high geriatric population to drive market 177
11.4.3 CHINA 180
11.4.3.1 Increasing number of hospitals and growing public access to modern healthcare to fuel market growth 180
11.4.4 INDIA 183
11.4.4.1 Large patient population and developed healthcare sector to boost market growth 183
11.4.5 AUSTRALIA 185
11.4.5.1 Increasing prevalence of chronic respiratory diseases to fuel market 185
11.4.6 SOUTH KOREA 188
11.4.6.1 Increasing private hospitals and growing medical tourism to support market growth 188
11.4.7 REST OF ASIA PACIFIC 190
11.5 LATIN AMERICA 192
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 195
11.5.2 BRAZIL 196
11.5.2.1 Developed public health systems and improved healthcare infrastructure to favor market growth 196
11.5.3 MEXICO 198
11.5.3.1 Modern healthcare infrastructure and availability of advanced surgical techniques to augment market growth 198
11.5.4 REST OF LATIN AMERICA 200
11.6 MIDDLE EAST & AFRICA 202
11.6.1 DEVELOPED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT HEALTH POLICIES TO PROPEL MARKET 202
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 205
11.7 GCC COUNTRIES 205
11.7.1 INCREASING GOVERNMENT HEALTHCARE SPENDING AND GROWING MEDICAL TOURISM TO AID MARKET GROWTH 205
11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 208
12 COMPETITIVE LANDSCAPE 209
12.1 INTRODUCTION 209
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 209
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BREATHING CIRCUITS MARKET 209
12.3 REVENUE ANALYSIS, 2021–2023 211
12.4 MARKET SHARE ANALYSIS, 2023 212
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 214
12.5.1 STARS 214
12.5.2 EMERGING LEADERS 214
12.5.3 PERVASIVE PLAYERS 214
12.5.4 PARTICIPANTS 214
12.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2023 216
12.5.5.1 Company footprint 216
12.5.5.2 Usage footprint 216
12.5.5.3 Application footprint 217
12.5.5.4 Region footprint 218
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 218
12.6.1 PROGRESSIVE COMPANIES 218
12.6.2 RESPONSIVE COMPANIES 219
12.6.3 DYNAMIC COMPANIES 219
12.6.4 STARTING BLOCKS 219
12.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023 220
12.7 COMPANY VALUATION AND FINANCIAL METRICS 221

12.8 BRAND/PRODUCT COMPARISON 222
12.9 COMPETITIVE SCENARIO 223
12.9.1 PRODUCT LAUNCHES 223
12.9.2 DEALS 224
13 COMPANY PROFILES 225
13.1 KEY PLAYERS 225
13.1.1 DRÄGERWERK AG & CO. KGAA 225
13.1.1.1 Business overview 225
13.1.1.2 Products offered 227
13.1.1.3 Recent developments 228
13.1.1.3.1 Product launches 228
13.1.1.3.2 Deals 228
13.1.1.4 MnM view 228
13.1.1.4.1 Key strengths 228
13.1.1.4.2 Strategic choices 229
13.1.1.4.3 Weaknesses and competitive threats 229
13.1.2 MEDTRONIC 230
13.1.2.1 Business overview 230
13.1.2.2 Products offered 231
13.1.2.3 Recent developments 232
13.1.2.3.1 Deals 232
13.1.2.4 MnM view 232
13.1.2.4.1 Key strengths 232
13.1.2.4.2 Strategic choices 233
13.1.2.4.3 Weaknesses and competitive threats 233
13.1.3 CARDINAL HEALTH 234
13.1.3.1 Business overview 234
13.1.3.2 Products offered 235
13.1.3.3 Recent developments 236
13.1.3.3.1 Expansions 236
13.1.3.4 MnM view 236
13.1.3.4.1 Key strengths 236
13.1.3.4.2 Strategic choices 236
13.1.3.4.3 Weaknesses and competitive threats 237
13.1.4 FISHER & PAYKEL HEALTHCARE LIMITED 238
13.1.4.1 Business overview 238
13.1.4.2 Products offered 239
13.1.4.3 Recent developments 240
13.1.4.3.1 Expansions 240
13.1.4.4 MnM view 240
13.1.4.4.1 Key strengths 240
13.1.4.4.2 Strategic choices 240
13.1.4.4.3 Weaknesses and competitive threats 240
13.1.5 RESMED 241
13.1.5.1 Business overview 241
13.1.5.2 Products offered 242
13.1.5.3 Recent developments 243
13.1.5.3.1 Expansions 243
13.1.5.4 MnM view 243
13.1.5.4.1 Key strengths 243
13.1.5.4.2 Strategic choices 243
13.1.5.4.3 Weaknesses and competitive threats 243
13.1.6 AMBU A/S 244
13.1.6.1 Business overview 244
13.1.6.2 Products offered 246
13.1.6.3 Recent developments 246
13.1.6.3.1 Expansions 246
13.1.7 GE HEALTHCARE 247
13.1.7.1 Business overview 247
13.1.7.2 Products offered 248
13.1.7.3 Recent developments 249
13.1.7.3.1 Deals 249
13.1.7.3.2 Expansions 249
13.1.8 KONINKLIJKE PHILIPS N.V. 250
13.1.8.1 Business overview 250
13.1.8.2 Products offered 251
13.1.8.3 Recent developments 252
13.1.8.3.1 Deals 252
13.1.9 ICU MEDICAL, INC. 253
13.1.9.1 Business overview 253
13.1.9.2 Products offered 255
13.1.9.3 Recent developments 255
13.1.9.3.1 Deals 255
13.1.10 HAMILTON MEDICAL 256
13.1.10.1 Business overview 256
13.1.10.2 Products offered 256
13.1.11 MEDLINE INDUSTRIES, LP 257
13.1.11.1 Business overview 257
13.1.11.2 Products offered 257
13.1.11.3 Recent developments 258
13.1.11.3.1 Deals 258
13.1.11.3.2 Expansions 259

13.2 OTHER PLAYERS 260
13.2.1 FORCA HEALTHCARE 260
13.2.2 BRAUN & CO. LIMITED 261
13.2.3 INSPIRATION HEALTHCARE GROUP PLC 262
13.2.4 BESMED HEALTH BUSINESS CORP. 263
13.2.5 EAKIN HEALTHCARE 264
13.2.6 BOMIMED 265
13.2.7 FLEXICARE (GROUP) LIMITED 266
13.2.8 BIO-MED DEVICES 267
13.2.9 AIRLIFE 268
13.2.10 MERCURY MEDICAL 269
13.2.11 INTERSURGICAL LTD. 270
13.2.12 FAIRMONT MEDICAL PRODUCTS PTY LTD. 271
13.2.13 BREAS MEDICAL AB 272
13.2.14 GPC MEDICAL LTD. 273
14 APPENDIX 274
14.1 DISCUSSION GUIDE 274
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 278
14.3 CUSTOMIZATION OPTIONS 280
14.4 RELATED REPORTS 280
14.5 AUTHOR DETAILS 281